Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1989 Sep;33(9):1652–1653. doi: 10.1128/aac.33.9.1652

Effects of reduced cation supplement recommendations (National Committee for Clinical Laboratory Standards) on daptomycin antistaphylococcal activity.

R N Jones 1
PMCID: PMC172727  PMID: 2554804

Full text

PDF
1652

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen N. E., Hobbs J. N., Alborn W. E., Jr Inhibition of peptidoglycan biosynthesis in gram-positive bacteria by LY146032. Antimicrob Agents Chemother. 1987 Jul;31(7):1093–1099. doi: 10.1128/aac.31.7.1093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Andrew J. H., Wale M. C., Wale L. J., Greenwood D. The effect of cultural conditions on the activity of LY146032 against staphylococci and streptococci. J Antimicrob Chemother. 1987 Aug;20(2):213–221. doi: 10.1093/jac/20.2.213. [DOI] [PubMed] [Google Scholar]
  3. Barry A. L., Miller G. H., Thornsberry C., Hare R. S., Jones R. N., Lorber R. R., Ferraresi R., Cramer C. Influence of cation supplements on activity of netilmicin against Pseudomonas aeruginosa in vitro and in vivo. Antimicrob Agents Chemother. 1987 Oct;31(10):1514–1518. doi: 10.1128/aac.31.10.1514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Eliopoulos G. M., Thauvin C., Gerson B., Moellering R. C., Jr In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic. Antimicrob Agents Chemother. 1985 Mar;27(3):357–362. doi: 10.1128/aac.27.3.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Faruki H., Niles A. C., Heeren R. L., Murray P. R. Effect of calcium on in vitro activity of LY146032 against Clostridium difficile. Antimicrob Agents Chemother. 1987 Mar;31(3):461–462. doi: 10.1128/aac.31.3.461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hamilton-Miller J. M. Nomenclature of LY146032. J Antimicrob Chemother. 1988 Jan;21(1):133–133. doi: 10.1093/jac/21.1.133. [DOI] [PubMed] [Google Scholar]
  7. Jones R. N., Barry A. L. Antimicrobial activity and spectrum of LY146032, a lipopeptide antibiotic, including susceptibility testing recommendations. Antimicrob Agents Chemother. 1987 Apr;31(4):625–629. doi: 10.1128/aac.31.4.625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lakey J. H., Ptak M. Fluorescence indicates a calcium-dependent interaction between the lipopeptide antibiotic LY146032 and phospholipid membranes. Biochemistry. 1988 Jun 28;27(13):4639–4645. doi: 10.1021/bi00413a009. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES